RU2012137785A - Лечение респираторных заболеваний - Google Patents
Лечение респираторных заболеваний Download PDFInfo
- Publication number
- RU2012137785A RU2012137785A RU2012137785/15A RU2012137785A RU2012137785A RU 2012137785 A RU2012137785 A RU 2012137785A RU 2012137785/15 A RU2012137785/15 A RU 2012137785/15A RU 2012137785 A RU2012137785 A RU 2012137785A RU 2012137785 A RU2012137785 A RU 2012137785A
- Authority
- RU
- Russia
- Prior art keywords
- oil
- acid
- composition
- derivative
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001912.3A GB201001912D0 (en) | 2010-02-05 | 2010-02-05 | Treatment of respiratory disorders |
| GB1001912.3 | 2010-02-05 | ||
| GB1015878A GB2477590A (en) | 2010-02-05 | 2010-09-22 | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
| GB1015878.0 | 2010-09-22 | ||
| PCT/GB2011/050189 WO2011095814A1 (en) | 2010-02-05 | 2011-02-04 | Treatment of respiratory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012137785A true RU2012137785A (ru) | 2014-03-10 |
Family
ID=43927856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012137785/15A RU2012137785A (ru) | 2010-02-05 | 2011-02-04 | Лечение респираторных заболеваний |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130178448A1 (enExample) |
| EP (1) | EP2531188A1 (enExample) |
| JP (1) | JP2013518869A (enExample) |
| CN (1) | CN102858333A (enExample) |
| AU (1) | AU2011212256A1 (enExample) |
| CA (1) | CA2788766A1 (enExample) |
| GB (1) | GB2477590A (enExample) |
| MX (1) | MX2012009052A (enExample) |
| NZ (1) | NZ601594A (enExample) |
| RU (1) | RU2012137785A (enExample) |
| SG (2) | SG183176A1 (enExample) |
| WO (1) | WO2011095814A1 (enExample) |
| ZA (1) | ZA201205829B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| GB201018289D0 (en) * | 2010-10-29 | 2010-12-15 | Biocopea Ltd | Treatment of respiratory disorders |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| RU2016138830A (ru) * | 2011-02-04 | 2018-12-12 | ИнФёрст Хэлткэр Лимитед | Составы и способы для лечения сердечно-сосудистых заболеваний |
| MX340951B (es) | 2011-09-29 | 2016-07-29 | Plx Pharma Inc | Portadores dependientes del ph para la liberacion dirigida de productos farmaceuticos a lo largo del tracto gastrointestinal, composiciones de los mismos, y fabricación y uso de las mismas. |
| WO2013143688A1 (en) | 2012-03-26 | 2013-10-03 | Glatt Ag | Taste-masked ibuprofen granules |
| CN103893171B (zh) * | 2014-04-19 | 2016-05-25 | 武汉胜达康生物科技有限公司 | 盐酸苄达明在制备治疗或预防流感病毒感染药物中的应用 |
| US20150343139A1 (en) * | 2014-05-30 | 2015-12-03 | Boston Scientific Scimed, Inc. | Implantable pumps and related methods of use |
| AR102172A1 (es) | 2015-10-05 | 2017-02-08 | Química Luar S R L | Una composición farmacéutica bactericida y virucida |
| CN109464670B (zh) * | 2017-09-08 | 2022-08-02 | 中国科学院微生物研究所 | 调控a型和b型流感病毒核蛋白出核的关键氨基酸位点及其作为抗流感病毒药物靶点的用途 |
| KR20220158031A (ko) | 2020-03-26 | 2022-11-29 | 피엘엑스 옵코 인코포레이티드 | pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법 |
| US12324853B2 (en) | 2020-08-10 | 2025-06-10 | Quimica Luar S.R.L. | Methods for treating respiratory viral infections |
| WO2022119756A1 (en) * | 2020-12-04 | 2022-06-09 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for inhibiting m pro protease activity and for preventing and treating sars-cov-2 infection |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4681897A (en) * | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| US4571400A (en) * | 1984-12-18 | 1986-02-18 | Belleview Pharmaceutical, Inc. | Dihydrocodeine/ibuprofen pharmaceutical compositions and method |
| US4684666A (en) * | 1986-08-19 | 1987-08-04 | Haas Pharmaceuticals, Inc. | Stabilized liquid analgesic compositions |
| CA1323306C (en) * | 1987-03-05 | 1993-10-19 | Mircea C. Popescu | Pharmacological agent-lipid solution preparation |
| US5059626A (en) | 1988-07-25 | 1991-10-22 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| US4918103A (en) * | 1988-07-25 | 1990-04-17 | Formulations Development Labs | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| US5011852A (en) * | 1988-07-25 | 1991-04-30 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| US5552160A (en) * | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
| ATE221379T1 (de) * | 1991-05-01 | 2002-08-15 | Jackson H M Found Military Med | Verfahren zur behandlung infektiöser respiratorischer erkrankungen |
| JPH069381A (ja) * | 1992-03-26 | 1994-01-18 | Toyo Capsule Kk | イブプロフェン含有軟カプセル剤 |
| US5955451A (en) * | 1995-05-12 | 1999-09-21 | The University Of Texas System Board Of Regents | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
| AU6390096A (en) * | 1995-07-20 | 1997-02-18 | Pharmacia & Upjohn Company | Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
| GB9625589D0 (en) * | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
| US6319513B1 (en) * | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| WO2002085414A2 (en) * | 2000-12-19 | 2002-10-31 | The Board Of Regents Of The University Of Texas System | Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| WO2002083105A2 (en) * | 2001-04-10 | 2002-10-24 | Zagros Pharma Inc. | Composition for enhanced absorption of nsaids |
| US7960416B2 (en) * | 2001-08-03 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Stable emulsion composition |
| US20030232097A1 (en) * | 2002-06-17 | 2003-12-18 | Strides Inc. | Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen |
| EP1539729A4 (en) * | 2002-07-03 | 2008-02-20 | Nitromed Inc | NITROSED NON-TESTED OXIDE COMPOUNDS, COMPOSITIONS, AND APPLICATION METHODS |
| KR100507771B1 (ko) * | 2002-11-08 | 2005-08-17 | 한미약품 주식회사 | 난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법 |
| PL1608407T3 (pl) * | 2003-03-20 | 2006-12-29 | Pharmacia Corp | Dyspergowana kompozycja środka przeciw-zapalnego |
| EP1651210A1 (en) * | 2003-07-31 | 2006-05-03 | Pharmacia & Upjohn Company LLC | Dispersible formulation of an anti-inflammatory agent |
| IL159729A0 (en) * | 2004-01-06 | 2004-06-20 | Doron I Friedman | Non-aqueous composition for oral delivery of insoluble bioactive agents |
| AU2005206084A1 (en) * | 2004-01-09 | 2005-08-04 | Wyeth | Microemulsions for pharmaceutical compositions |
| WO2006099325A2 (en) * | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of treating ear infections |
| US20070092559A1 (en) * | 2005-10-24 | 2007-04-26 | Jinghua Yuan | Liquid dosage forms having enteric properties of delayed and then sustained release |
| RU2009103000A (ru) * | 2006-06-30 | 2010-08-10 | МакНЕЙЛ-ППС, ИНК. (US) | Твердые капсулы, наполненные жидкостью, содержащей ибупрофен |
| JP2008143807A (ja) * | 2006-12-07 | 2008-06-26 | Sato Pharmaceutical Co Ltd | 感冒薬カプセル剤及びその製造方法 |
| WO2009069139A1 (en) * | 2007-11-28 | 2009-06-04 | Alkem Laboratories Ltd. | Dosage form providing an ibuprofen-containing liquid fill |
| JP2009155282A (ja) * | 2007-12-27 | 2009-07-16 | Kowa Co | 固体分散体含有医薬組成物 |
| CN102341125B (zh) * | 2008-11-19 | 2014-02-12 | 梅里亚有限公司 | 包含头孢噻呋和酮洛芬或头孢噻呋和苯甲醇的配制剂 |
| JP2012519159A (ja) * | 2009-02-27 | 2012-08-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４阻害剤及びｎｓａｉｄを含有する複合薬 |
| WO2010097334A1 (de) * | 2009-02-27 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids |
-
2010
- 2010-09-22 GB GB1015878A patent/GB2477590A/en not_active Withdrawn
-
2011
- 2011-02-04 CA CA2788766A patent/CA2788766A1/en not_active Abandoned
- 2011-02-04 WO PCT/GB2011/050189 patent/WO2011095814A1/en not_active Ceased
- 2011-02-04 RU RU2012137785/15A patent/RU2012137785A/ru not_active Application Discontinuation
- 2011-02-04 CN CN2011800180526A patent/CN102858333A/zh active Pending
- 2011-02-04 SG SG2012057865A patent/SG183176A1/en unknown
- 2011-02-04 NZ NZ601594A patent/NZ601594A/en not_active IP Right Cessation
- 2011-02-04 EP EP11702694A patent/EP2531188A1/en not_active Withdrawn
- 2011-02-04 JP JP2012551685A patent/JP2013518869A/ja active Pending
- 2011-02-04 MX MX2012009052A patent/MX2012009052A/es active IP Right Grant
- 2011-02-04 US US13/576,758 patent/US20130178448A1/en not_active Abandoned
- 2011-02-04 SG SG10201500899VA patent/SG10201500899VA/en unknown
- 2011-02-04 AU AU2011212256A patent/AU2011212256A1/en not_active Abandoned
-
2012
- 2012-08-02 ZA ZA2012/05829A patent/ZA201205829B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130178448A1 (en) | 2013-07-11 |
| GB2477590A (en) | 2011-08-10 |
| CA2788766A1 (en) | 2011-08-11 |
| SG183176A1 (en) | 2012-09-27 |
| NZ601594A (en) | 2014-10-31 |
| AU2011212256A1 (en) | 2012-08-23 |
| SG10201500899VA (en) | 2015-04-29 |
| JP2013518869A (ja) | 2013-05-23 |
| CN102858333A (zh) | 2013-01-02 |
| EP2531188A1 (en) | 2012-12-12 |
| GB201015878D0 (en) | 2010-10-27 |
| MX2012009052A (es) | 2012-11-29 |
| ZA201205829B (en) | 2013-05-29 |
| WO2011095814A1 (en) | 2011-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012137785A (ru) | Лечение респираторных заболеваний | |
| JP2013518869A5 (enExample) | ||
| RU2013124514A (ru) | Воспалительное заболевание | |
| JP2015527386A5 (enExample) | ||
| ES2906571T3 (es) | Composiciones de soluciones sólidas para AINEs | |
| RU2015134142A (ru) | Композиции твердых растворов и их применение при сильной боли | |
| RU2015134136A (ru) | Композиции и способы для лечения сильной боли | |
| HRP20200068T1 (hr) | Etilni ester ikozapentaenske kiseline, namijenjen liječenju hipertrigliceridemije | |
| JP2010521442A5 (enExample) | ||
| AR109789A2 (es) | Compuestos lipídicos | |
| CO6220926A2 (es) | Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid) | |
| JPH07304688A (ja) | 非ステロイド系抗炎症性薬物、その製造法およびそれを含有する薬剤 | |
| Wallace et al. | Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis | |
| RU2007139819A (ru) | Композиции с гидрофильными лекарствами в гидрофобной среде | |
| JP2013515742A5 (enExample) | ||
| JP2008540394A5 (enExample) | ||
| WO2012127037A3 (en) | A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative | |
| JP2012513774A (ja) | ニトロ脂肪酸を含有する栄養補助物 | |
| JP2016508155A5 (enExample) | ||
| JP2012524771A5 (enExample) | ||
| JP2013515018A5 (enExample) | ||
| JP2014509655A5 (enExample) | ||
| JP2013529646A (ja) | ナイアシン模倣体、およびその使用方法 | |
| RU2017104993A (ru) | Фармацевтическая композиция, включающая ингибитор 5-альфа редуктазы | |
| NZ596946A (en) | Solid compositions comprising 5-aminolevulinic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant | ||
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20151020 |